1,2,3,4-tetrahydroquinoline has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, LY; Chen, XY; Dai, Z; Di, B; Hou, CZ; Jiang, C; Li, CC; Li, K; Xu, LL; Yang, F; You, QD; You, ST; Zhao, N | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Colitis
Article | Year |
---|---|
Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Colitis; Dextran Sulfate; Drug Design; Female; Humans; Inhibitory Concentration 50; Interleukin-1beta; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Quinolines; Reactive Oxygen Species; Structure-Activity Relationship | 2021 |